Critical update: Change to Drug Price Transparency support contact
The Health Care Authority (HCA) is writing you with new information critical to the Drug Price Transparency (DPT) program.
What is the change?
Effective immediately, the HCA will manage two different inboxes to support the management and processes of the DPT program.
HCA Drug Price Transparency - general inquiries
Email address: drugtransparency@hca.wa.gov
This inbox should be used for program questions and information only.
- Registration
- Password information for SFT site
- Extension requests
- Questions related to compliance and deadlines
- General questions about the WAC (rule), RCW, and submission guides
- Stakeholder feedback on submission guides
- Any questions that are legal in nature
Do not send confidential or proprietary information to this inbox.
HCA Drug Price Transparency - tech support
Email address: HCADPTTechSupport@hca.wa.gov
Should be used only for technical data related questions, or any questions regarding the data submission process.
- Error logs and any supplemental attachments
- Data definitions and requirements as outlined by the data submission guide
Questions?
If you have any questions regarding the information contained in this notification, please email our general inquiry inbox.
|